Fluorescence in situ hybridization as prognostic predictor of tumor recurrence during treatment with Bacillus Calmette–Guérin therapy for intermediate- and high-risk non-muscle-invasive bladder cancer

Documenti analoghi

• Confocal Laser Endomicroscopy for the Diagnosis of Urothelial Carcinoma in the Bladder and the Upper Urinary Tract: Protocols for Two Prospective Explorative Studies
  di: Liem, Esmee IML, et al.
  Pubblicazione: (2018)
• Emerging optical techniques in advanced cystoscopy for bladder cancer diagnosis: A review of the current literature
  di: Cauberg Evelyne, C.C., et al.
  Pubblicazione: (2011)
• Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guérin, and Bacillus Calmette-Guérin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder
  di: Sylvester, Richard J., et al.
  Pubblicazione: (2009)
• Narrow band imaging-assisted transurethral resection for non-muscle invasive bladder cancer significantly reduces residual tumour rate
  di: Cauberg, Evelyne C. C., et al.
  Pubblicazione: (2011)
• THE CALMETTE-GUÉRIN VACCINE
  Pubblicazione: (1929)